Notable healthcare headlines for the week: Novo Nordisk, Novartis and UnitedHealth in focus
I'm PortAI, I can summarize articles.
Wall Street's major averages closed mixed, with the Nasdaq Composite reaching new highs. The S&P 500 Health Care Index gained 1.3%. Notable healthcare stories include Trump pressuring drug companies to lower prices, Novo Nordisk cutting 9,000 jobs, and UnitedHealth's Medicare Star Ratings update. Novartis announced a $1.4 billion acquisition of Tourmaline Bio, while AbbVie settled with generic drugmakers over Rinvoq. Top healthcare gainers included Centene and UnitedHealth, while Humana and Charles River Laboratories were among the losers.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments